MOLCURE was founded in 2013 with a mission to build the best platform for biologics discovery in the world. Today, its platform integrates AI with evolutionary molecular engineering, next-generation sequencing, laboratory automation technologies, and a proprietary database containing more than one billion molecular entries. These capabilities enable the delivery of diverse, high affinity, specific, and functional antibodies and peptides for researchers. MOLCURE is partnering with innovative companies to discover therapeutics with the potential to benefit patients around the world.
Looking for a particular MOLCURE Inc. employee's phone or email?
The MOLCURE Inc. annual revenue was $1 million in 2026.
Ryu Ogawa is the Founder, CIO(Chief Innovation Officer) of MOLCURE Inc..
17 people are employed at MOLCURE Inc..
MOLCURE Inc. is based in Tokyo, Tokyo.
The NAICS codes for MOLCURE Inc. are [541713, 541, 54, 5417, 54171].
The SIC codes for MOLCURE Inc. are [87, 873].